• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·VRL.BO
Share

Vasundhara Rasayans Limited Stocks

₹ 174.5Last Updated 28.07.2026

Issuer Rating

5/7
Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

₹ 5.62M

₹ 174.5
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Vasundhara Rasayans Ltd. focuses on developing and globally supplying active pharmaceutical ingredients (APIs) primarily for use in antacid medications. The company's product line is offered in several physical states, including paste, conventional powder, and a finely processed micronized powder. Its commercial reach extends across both international export and the local domestic market segments. Established on March 5, 1987, the enterprise maintains its central corporate office in Hyderabad, India.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued o

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

30.07.2026 17:35

Egypt reported a drone attack on ships in a Mediterranean port

30.07.2026 17:11

The fund run by the 24-year-old “AI Nostradamus” needed new capital following the tech sector’s downturn

30.07.2026 16:50

Shares of the micro-cap biotech company Processa plummeted following the announcement of a merger. What went wrong?

30.07.2026 16:15

Opinion: The AI Boom vs. the Dot-Com Era. What Are Their Main Differences?

30.07.2026 15:50

July Could Be the Worst Month for Chinese Stocks in 10 Years

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026